Intelligence · Clinical Development
Pipeline search results
Programs matching “capecitabine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 38 pipeline programs matching "capecitabine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CAPECITABINE
Disc Medicine
Salivary Duct Carcinoma
1 trial -
CAPECITABINE for Locally advanced stage II/III rectal cancer
Fondazione Telethon ETS
Locally advanced stage II/III rectal cancer
1 trial -
Capecitabine
Pfizer
Breast Neoplasms
1 trial -
Capecitabine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Capecitabine
Hoffmann-La Roche
Gastric Cancer
1 trial -
Capecitabine monotherapy
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Capecitabine plus temozolamide
Hospital Authority, Hong Kong
Neuroendocrine Neoplasia's (NENs)
1 trial -
Capecitabine(Aibin)
The First People's Hospital of Lianyungang
Stage III Esophageal Squamous Cell Carcinoma
1 trial -
Carrellizumab + Capecitabine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Neoplasms
1 trial -
Ixabepilone + Capecitabine
Semnur Pharmaceuticals
Breast Cancer
1 trial -
metronomic adjuvant chemotherapy with capecitabine
Chongqing Claruvis Pharmaceutical Co.,
Nasopharyngeal Cancinoma (NPC)
1 trial -
BFH-NCRTPD
BEONE MEDICINES AUS PTY LTD
Colorectal Neoplasms
1 trial -
CAPECITABINE , OXALIPLATIN
Disc Medicine
Patients with early-stage rectal cancer (defined as early rectal cancer cT1-3abN0M0 or early-intermediate rectal cancer cT1-3abN1(≤3 nodes ≤8mm)M0
1 trial -
CAPECITABINE , VALPROIC ACID
Fondazione Telethon ETS
low- risk rectal cancel
1 trial -
CAPECITABINE for Colon cancer
Fondazione Telethon ETS
Colon cancer
1 trial -
CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
BEONE MEDICINES AUS PTY LTD
Nasopharyngeal Carcinoma
1 trial -
Capecitabine
xie congying
Gastric Cancer
1 trial -
Capecitabine
The University of Hong Kong
Pancreatic Adenocarcinoma
1 trial -
Capecitabine
PUMA BIOTECHNOLOGY, INC.
Breast Cancer
1 trial -
Capecitabine
Novartis Pharmaceuticals
Breast Cancer
1 trial -
Capecitabine
Regeneron UK Limited
Colorectal Cancer Metastatic
1 trial -
Capecitabine
The First People's Hospital of Lianyungang
Biliary Carcinoma
1 trial -
Capecitabine
Vera Therapeutics
Breast Cancer
1 trial -
Capecitabine Accord 500 mg film-coated tablets
Ningbo Cancer Hospital
Biliary tract cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.